By Counterforce Health Team in Upstaza (eladocagene exuparvovec) —

How to Get Upstaza (Eladocagene Exuparvovec) Covered by Cigna in Florida: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Upstaza Covered by Cigna in Florida

Upstaza (eladocagene exuparvovec) requires prior authorization from Cigna through Express Scripts/Accredo. In Florida, you have strong appeal rights if denied. Quick path: 1) Confirm AADC deficiency diagnosis with genetic testing, 2) Submit PA via Accredo CoverMyMeds portal with medical necessity letter, 3) If denied, file internal appeal within 180 days citing Florida step therapy protections under HB 459. External review available through Florida Department of Financial Services within 4 months of final denial.

Table of Contents

Why Florida State Rules Matter

Florida's insurance landscape includes unique protections that can help you get Upstaza approved, even when Cigna initially denies coverage. The state's HB 459 step therapy law (effective July 2022) restricts insurers from requiring you to fail cheaper drugs first when medical evidence supports going straight to the needed treatment.

For gene therapy like Upstaza, this matters because there are no direct alternatives—supportive care doesn't provide the same disease-modifying effects. Florida also strengthened appeal timelines in 2025, requiring physician review of medical necessity denials rather than algorithm-only decisions.

Note: Florida Blue dominates the state with 36% market share, but Cigna members have similar appeal rights under state and federal law.

Prior Authorization Requirements

Cigna manages specialty drugs through Express Scripts and Accredo. For Upstaza, expect these requirements:

Coverage at a Glance

Requirement Details Where to Find
PA Required Yes, high-cost gene therapy Cigna formulary exception process
Diagnosis AADC deficiency with genetic confirmation FDA label requirements
Age Limit ≥18 months with skull maturity Kebilidi prescribing info
Administration Certified neurosurgical center only University of Florida PGTC likely candidate
Review Time 72 hours standard, 24 hours expedited Express Scripts PA FAQ

Step-by-Step: Fastest Path to Approval

  1. Confirm Eligibility (Patient/Family)
    • Obtain genetic testing results confirming AADC deficiency
    • Schedule imaging to verify skull maturity (≥18 months)
    • Expected timeline: 2-4 weeks
  2. Find Certified Center (Patient/Clinician)
    • Contact PTC Therapeutics PTCcares.com for approved facilities
    • University of Florida's Powell Gene Therapy Center has AADC expertise
    • Expected timeline: 1-2 weeks for referral
  3. Submit Prior Authorization (Clinician)
    • Use Accredo CoverMyMeds portal or call 800-753-2851
    • Include medical necessity letter (see template below)
    • Expected timeline: 72 hours for decision
  4. Track Status (Patient)

Step Therapy Protections in Florida

Florida's HB 459 gives you automatic exemptions from step therapy when:

  • Previous approval: You received the drug under another plan within the past 90 days with documentation
  • Medical contraindication: The required "step" drug isn't FDA-approved for AADC deficiency (which it won't be—there are no alternatives)
  • Clinical failure: Prior trials of supportive care haven't provided adequate symptom control

How to Request Step Therapy Override

Submit via your insurer's published exemption process (Cigna must provide forms on their website per Florida law). Include:

  • Prescriber attestation that step therapy is inappropriate
  • Clinical evidence showing Upstaza is the only disease-modifying option
  • Documentation that delay could worsen neurological function
From our advocates: "We've seen Florida patients successfully argue that requiring 'supportive care trials' for AADC deficiency violates the step therapy law, since supportive care isn't FDA-approved to restore enzyme function like Upstaza. The key is having your neurologist explain why delay risks permanent developmental losses."

Continuity of Care Rights

If you're already receiving Upstaza follow-up care and face a network change, Florida provides transition protections:

When Protections Apply

  • Your treating neurosurgical center leaves Cigna's network
  • You switch from another plan to Cigna mid-treatment
  • Your specialist moves to a different practice

What You Can Request

  • Time-limited in-network coverage (typically 60-90 days) to continue with your current provider
  • Honor existing authorizations during the transition period
  • Out-of-network exception if no comparable in-network gene therapy center exists

Contact Cigna member services and specifically request a "continuity of care arrangement" for ongoing gene therapy follow-up.

Appeals Process: Internal to External

Internal Appeals with Cigna

Appeal Level Who Can File Deadline Processing Time How to Submit
Level 1 Patient, representative, or physician 180 days from denial Up to 45 days Cigna appeals process
Level 2 Provider only 60 days from Level 1 decision Up to 45 days Written request to Cigna

External Review in Florida

If internal appeals fail, you can request independent review through the Florida Department of Financial Services:

  • Deadline: 4 months from final internal denial
  • Cost: Free to patients (insurer pays)
  • Timeline: 45 days standard, 72 hours expedited
  • Decision: Binding on Cigna

Call the DFS Consumer Helpline at 1-877-693-5236 to start the external review process.

Medical Necessity Documentation

Your neurologist's letter should address these key points for Upstaza approval:

Required Elements

  • Confirmed AADC deficiency with genetic testing results and enzyme levels
  • Severity assessment showing developmental delays and motor dysfunction
  • Prior treatments tried (supportive care, medications) and their limitations
  • Clinical rationale for gene therapy as disease-modifying treatment
  • Center certification confirming qualified neurosurgeon and proper facilities
  • Monitoring plan for post-procedure care and outcome assessment

Supporting Evidence to Include

  • FDA approval documentation for AADC deficiency
  • Published studies on putamen gene therapy outcomes
  • Growth charts showing developmental plateaus despite supportive care
  • Imaging confirming skull maturity and putamen anatomy

Counterforce Health helps clinicians draft evidence-backed medical necessity letters that align with payer requirements and cite the right clinical guidelines for gene therapy approvals.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Key Documents
"Experimental/investigational" Cite FDA approval (August 2024) FDA approval announcement
"Not medically necessary" Emphasize no alternative disease-modifying therapy Comparative effectiveness literature
"Non-certified facility" Confirm center has trained neurosurgeon University of Florida PGTC credentials
"Age restrictions" Submit skull maturity imaging Radiology report confirming bone development
"Step therapy required" Invoke Florida HB 459 exemptions Step therapy override request form

Cost Support and Patient Assistance

Given Upstaza's multimillion-dollar price tag, explore these options:

Manufacturer Support

  • PTC Cares: Patient assistance through PTCcares.com
  • Copay assistance: May cover out-of-pocket costs up to annual limits
  • Case management: Help navigating insurance approval process

Foundation Grants

  • National Organization for Rare Disorders (NORD) patient assistance
  • HealthWell Foundation rare disease fund
  • Good Days chronic disease assistance

State Resources

Contact the Florida Department of Health Children's Medical Services for additional support programs for rare pediatric conditions.

FAQ

How long does Cigna prior authorization take for Upstaza in Florida? Standard review is 72 hours, expedited is 24 hours. You can request expedited review if delay could worsen neurological function.

What if Upstaza isn't on Cigna's formulary? Request a formulary exception using Cigna's non-covered medication process. Emphasize lack of therapeutic alternatives.

Can I appeal if my child is under 18 months? Yes, but you'll need compelling evidence that delaying until skull maturity poses greater risks than early intervention.

Does Florida's step therapy law help with gene therapy denials? Absolutely. Since no other drugs provide the same disease-modifying effects as Upstaza, requiring "step therapy" with supportive care violates Florida's medical appropriateness standards.

How do I find a certified treatment center in Florida? Contact PTC Therapeutics directly. University of Florida's Powell Gene Therapy Center has extensive AADC deficiency experience and is likely to be certified.

What happens if external review upholds the denial? The decision is binding, but you can still pursue manufacturer patient assistance, clinical trials, or legal review for potential coverage violations.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on your specific plan terms and medical circumstances. Consult with your healthcare provider and insurance plan for personalized guidance.

For additional support navigating complex insurance approvals, Counterforce Health specializes in turning denials into targeted, evidence-backed appeals for specialty medications and gene therapies.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.